What is the appropriate diagnosis and treatment for a patient with left scrotal pain, intermittent pelvic pain, daytime urinary frequency, urgency, and nighttime incontinence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Management of Chronic Pelvic Pain Syndrome with Urinary Symptoms

This patient most likely has Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC) or Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS), and should be treated with a multimodal approach targeting bladder-related pain while ruling out infection and other identifiable causes. 1, 2

Primary Diagnostic Considerations

Most Likely Diagnosis: PBS/IC or CP/CPPS

The constellation of left scrotal pain, intermittent pelvic pain, daytime urinary frequency, urgency, and nighttime incontinence strongly suggests PBS/IC or CP/CPPS in this male patient. 1, 2

In men, PBS/IC should be strongly considered when pain, pressure, or discomfort is perceived to be related to the bladder and associated with urinary frequency, nocturia, or an urgent desire to void. 1, 2 The scrotal and pelvic pain distribution is characteristic of CP/CPPS, which shares overlapping features with PBS/IC. 1

Key Distinguishing Features

Pain is the hallmark symptom that differentiates PBS/IC from overactive bladder (OAB). 1, 2 This patient's presentation includes:

  • Pelvic and scrotal pain (characteristic of PBS/IC/CP/CPPS, not typical of pure OAB) 1, 2
  • Urinary frequency and urgency (present in both conditions but qualitatively different) 1
  • Nighttime incontinence (suggests urgency-related voiding to relieve pain rather than to avoid incontinence) 1, 2

PBS/IC patients typically void to avoid or relieve pain, whereas OAB patients void to avoid incontinence. 1, 2 The presence of pain makes PBS/IC/CP/CPPS the primary diagnosis. 1

Essential Diagnostic Workup

Mandatory Initial Testing

Perform urinalysis and urine culture immediately to exclude urinary tract infection, as PBS/IC is defined by the absence of infection or other identifiable causes. 1, 2, 3 This is critical because antibiotics should not be used when no infection is present, which can lead to antibiotic resistance. 2

Post-Void Residual Measurement

Measure post-void residual (PVR) to rule out overflow incontinence, particularly given the nighttime incontinence. 4 An elevated PVR (>250-300 mL) would suggest overflow incontinence and completely change the treatment approach. 4 This is a critical pitfall to avoid—misdiagnosing overflow incontinence as OAB or PBS/IC can lead to inappropriate antimuscarinic therapy that worsens retention. 4

Physical Examination Specifics

Perform a focused examination including:

  • Abdominal examination to assess for bladder distention or masses 4
  • Genital examination to evaluate for scrotal pathology, testicular tenderness, or epididymitis 1
  • Digital rectal examination to assess prostate size, tenderness, and rule out obstruction 1, 4

Voiding Diary

Obtain a voiding diary to document frequency patterns, voided volumes, and timing of symptoms. 1, 3 This reliably measures urinary frequency and can distinguish between small-volume voids (typical of PBS/IC/OAB) versus large-volume voids (suggesting nocturnal polyuria). 1, 3

Differential Diagnosis Algorithm

Rule Out These Conditions First:

  1. Urinary tract infection (urinalysis/culture) 2, 3
  2. Overflow incontinence (PVR measurement) 4
  3. Nocturnal polyuria (voiding diary showing normal/large volume nocturnal voids) 1, 3
  4. Bladder outlet obstruction (history of obstructive symptoms, enlarged prostate on exam) 1

If Above Are Excluded:

The diagnosis is PBS/IC, CP/CPPS, or both conditions coexisting. 1, 2 Some men meet criteria for both conditions, and the clinical characteristics are similar. 1

Treatment Approach

Initial Management Strategy

Begin treatment after a relatively short symptomatic period (6 weeks) to minimize delays, as definitions requiring longer durations can lead to misdiagnosis and treatment delays. 2

First-Line Therapies for PBS/IC/CP/CPPS:

Behavioral modifications:

  • Identify and avoid dietary triggers (foods/drinks that worsen pain) 1, 2
  • Bladder training techniques 5
  • Pelvic floor physical therapy 5, 6

Pharmacological options:

  • Analgesics for pain management 6
  • Alpha-receptor blockers (particularly useful in men with CP/CPPS features) 6
  • Antimuscarinic therapy (e.g., oxybutynin) may be considered for urgency/frequency symptoms, but ONLY if PVR is normal (<250 mL) 4, 7

Critical Pitfall to Avoid

Do NOT prescribe antimuscarinic medications if PVR is elevated (>250-300 mL), as this will worsen urinary retention. 4 This is why measuring PVR before initiating therapy is essential.

When to Consider Cystoscopy

Perform cystoscopy if Hunner lesions are suspected, as this is the only reliable way to diagnose their presence and may guide specific treatment. 2 However, cystoscopy is not required for initial diagnosis in most cases. 1, 2

Treatment for Coexisting Conditions

If the patient meets criteria for both PBS/IC and CP/CPPS (which is common), the treatment approach should include established PBS/IC therapies as well as therapies more specific to CP/CPPS. 1 Empiric PBS/IC strategies have led to clinical symptomatic improvement in some CP/CPPS patients. 1

Common Diagnostic Pitfalls

  • Using research definitions requiring 6+ months of symptoms delays treatment initiation 2
  • Failing to distinguish pain-predominant conditions (PBS/IC) from urgency-predominant conditions (OAB) 1, 2
  • Not measuring PVR before prescribing antimuscarinics 4
  • Treating with antibiotics when no infection is present 2
  • Assuming all urgency/frequency is OAB without assessing for pain 1, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Painful Bladder Syndrome (PBS)/Interstitial Cystitis (IC) Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Overactive Bladder Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Overflow Incontinence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended management for a 68-year-old male, status post Rezum (transurethral water vaporization) for Benign Prostatic Hyperplasia (BPH) and obstructive symptoms 2 months ago, presenting with worsening urge incontinence over the past month?
What is the best course of treatment for a 71-year-old male with Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) who is currently taking tamsulosin (flomax) 0.4mg twice daily, presenting with weak urinary stream, intermittent urinary incontinence, urgency, and nocturia, and has multiple comorbidities including type 2 diabetes, Coronary Artery Disease (CAD), Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), hypertension, and Chronic Kidney Disease (CKD) stage 2?
What is the appropriate workup and management for a 75-year-old male presenting with urinary urgency, frequency, weak stream, and bowel incontinence?
What is the strongest risk factor for an inguinal hernia in a 70-year-old male with a 50-year history of smoking 2 packs per day, experiencing nocturia (frequent urination at night) and dysuria (painful urination), likely due to benign prostatic hyperplasia (BPH)?
What are the next steps for a 54-year-old male with dysuria (painful urination) and a slow urine stream, but normal Prostate-Specific Antigen (PSA) level and no Urinary Tract Infection (UTI)?
When do you stop potassium transfusion in a mildly hypokalemic pediatric patient?
What investigations should be done for a first-time unprovoked Pulmonary Embolism (PE)?
Is a Prostate-Specific Antigen (PSA) level of 9 ng/mL concerning in an elderly male?
What are the contraindications for ketamine?
What is the management of hyperinsulinemia (high insulin levels) induced hypoglycemia (low blood sugar)?
What is rapid systolic flow in the left ventricular outflow tract (LVOT)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.